Trials / Not Yet Recruiting
Not Yet RecruitingNCT07316062
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
A Multi-centre Chart Review Study on the Treatment Patterns and Outcomes of Stage I-III Non-Small Cell Lung Cancer in China
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This chart review study is proposed in China to understand the treatment patterns, biomarker testing, and clinical outcomes with SOC and some selected regimens among patients diagnosed with stage I-III NSCLC.
Detailed description
The primary objective of this study is to understand the evolution of initial treatment patterns among patients with early-stage (I-III) NSCLC.
Conditions
Timeline
- Start date
- 2026-04-15
- Primary completion
- 2029-04-30
- Completion
- 2029-04-30
- First posted
- 2026-01-05
- Last updated
- 2026-01-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07316062. Inclusion in this directory is not an endorsement.